West Pharmaceutical Services, Inc. (WST) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate West Pharmaceutical Services, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
AnnualPro+QuarterlyPro+Unlock Annual & QuarterlyOne Pro+ plan · both periods
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
40.28
Weak
WeakModerateStrong
P/B Ratio
6.26
Weak
WeakModerateStrong
Earnings Yield
2.48%
Yield Trap
WeakModerateStrong
Profitability Health
TTMReturn on Equity
15.54%
Strong
WeakModerateStrong
Operating Margin
20.09%
Strong
WeakModerateStrong
Net Profit Margin
16.06%
Strong
WeakModerateStrong
Efficiency & Liquidity
TTMCurrent Ratio
3.02
Strong
WeakModerateStrong
Quick Ratio
2.34
Strong
WeakModerateStrong
Asset Turnover
0.72x
Moderate
WeakModerateStrong
Inventory Turnover
4.44x
Moderate
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
2.36%
Weak
WeakModerateStrong
EV / Free Cash Flow
41.63x
Weak
WeakModerateStrong
Net Debt / EBITDA
-0.52x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.997
Strong
WeakModerateStrong
Return on Invested Capital
13.62%
Weak
WeakModerateStrong
Cash Conversion Cycle
103.44 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for WST.
View Financial Statements